NXEN Projected Dividend Yield
Nexien BioPharma Inc ( OTCBB : NXEN )Nexien BioPharma is engaged in pursuing pre-clinical and drug development activities for certain pharmaceutical formulations that include cannabinoids. Co.'s subsidiary, CRx Bio Holdings LLC, is engaged in the research and development of cannabinoid formulations and drug delivery systems with a focus on bioavailability and related pharmacokinetics and pharmacodynamics improvement. Co. has three U.S. provisional patent applications relating to cannabinoid formulations to treat convulsive disorders, chronic traumatic encephalopathy, and neuropathic pain. Co. focuses its efforts on developing formulations that have the potential to improve the treatment of epilepsy and myotonic dystrophy. 20 YEAR PERFORMANCE RESULTS |
NXEN Dividend History Detail NXEN Dividend News NXEN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |